An anti-apoptotic effect of ROCK1 has been reported in bladder cancer [25] and leukemia [26], and it was demonstrated that ROCK1 can disrupt the apoptotic-signaling cascade through inhibitory binding to Erk1/2 kinase [26]. This evidence concerns the gene MAPK3 and urinary bladder carcinoma.